Clinical insight, skin science, and perspectives on precision medicine, skin of color, Ayurveda, and the future of medical aesthetics.
The goal of aesthetic medicine is not to reverse time. It is to help you look like the version of yourself you already feel on the inside. That distinction changes everything about how we approach a treatment plan.
Collagen loss begins earlier than most people realize. Here is the science behind it and the evidence base for the treatments that address it.
Volume loss and laxity originate deep in the structural tissue of the face. Understanding this changes how we think about treatment sequencing.
The biology of cellular aging shows up on the skin before it shows up anywhere else. Here is what the research says and what we can do about it.
The majority of clinical research and device testing in medical aesthetics has been conducted on Fitzpatrick Types I through III. Here is what that means for patients with deeper skin tones, and how to navigate treatment safely.
PIH affects patients of all skin tones but presents differently and requires different management depending on melanin concentration.
Melasma is among the most complex pigmentation concerns in dermatology, and it is disproportionately undertreated in patients of color.
The Fitzpatrick scale is a useful clinical tool, but it was designed in 1975 for a narrow patient population. Here is what it captures and what it misses.
For transgender and non-binary patients on hormone therapy, skin changes are among the most visible and meaningful physical shifts. Understanding them clinically makes care more precise and more affirming.
Gay men have distinct patterns of skin aging influenced by lifestyle, UV exposure, and historically limited access to tailored aesthetic care.
Beyond inclusivity language, what does it mean to genuinely build a practice for LGBTQ+ patients? A look at the clinical and operational choices that matter.
Metabolic microbiome profiling moves skin longevity from intuition to molecular data. Here is what it measures, what it reveals, and how it changes the way we build protocols.
Genetic testing in aesthetics is powerful but often misunderstood. Here is a clear-eyed look at what the five SkinDNA categories reveal about your skin's future.
Visia captures eight clinical metrics, including subsurface UV damage and bacterial activity that won't appear on the surface for years. Here is what we see and what we do with it.
Ayurvedic constitutional typing has been practiced for thousands of years. Modern genomic and microbiome research is beginning to validate what it has always described. Here is where the science stands.
Vata skin is not simply dry skin. It is a constitutional pattern that shapes how your skin responds, ages, and heals. Understanding it changes how we treat it.
Two patients with the same skin tone and the same concern can need completely different protocols. The 42-profile system explains why, and what we do about it.
Hormonal health, inflammation, and systemic wellbeing all show up on the skin. Sexual health is part of that picture, and it deserves the same clinical attention as any other factor we assess.
PrEP is life-changing medication. Understanding its dermatological implications helps patients make more informed decisions about their full health picture.
Sex hormones are among the most powerful drivers of skin behavior. Here is what the research shows about their role in aging, oiliness, pigmentation, and barrier function.
Join the waitlist and be the first to receive new articles, clinical insights, and early access when Aahana opens.